Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ULTRAGENYX PHARMACEUTICAL INC.

(RARE)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
40.17 USD   +6.24%
11/29Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-29-2022 10:00 AM
CI
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
11/22Ultragenyx to Present at Piper Sandler Healthcare Conference
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart ULTRAGENYX PHARMACEUTICAL INC.
Upcoming events on ULTRAGENYX PHARMACEUTICAL INC.
02/16/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
10/31/23 Q3 2023 Earnings Release (Projected)
Past events on ULTRAGENYX PHARMACEUTICAL INC.
11/29/22 | 10:00am Piper Sandler Healthcare Conference
11/17/22 | 05:25am Jefferies London Healthcare Conference
11/15/22 | 01:50pm Stifel Healthcare Conference
11/02/22 | 04:00pm Q3 2022 Earnings Call
11/02/22 | 03:05pm Q3 2022 Earnings Release
09/12/22 | 12:45pm American Society for Bone and Mineral Research Conference - Oral Presentation No - 1112
09/11/22 | 02:00pm American Society for Bone and Mineral Research Conference - Poster No - SUN-667
09/10/22 | 02:00pm American Society for Bone and Mineral Research Conference - Poster No - LB SAT-897
09/07/22 | 11:20am Citi BioPharma Conference
07/28/22 | 05:00pm Interim 2022 Earnings Call
Past dividends on ULTRAGENYX PHARMACEUTICAL INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
2,61
0,53
390%
51,5
48,4
6,3%
104
103
1,0%
271
250
8,4%
351
352
-0,12%
 
365
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-323
-322
-0,30%
-352
-366
3,9%
-416
-421
1,2%
-318
-287
-11%
-368
-343
-7,4%
 
-561
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-329
-319
-3,0%
-371
-376
1,2%
-424
-429
1,1%
-330
-303
-8,9%
-382
-369
-3,6%
 
-617
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-318
-309
-3,1%
-197
-202
2,2%
-399
-382
-4,5%
-185
-237
22%
-453
-422
-7,3%
 
-677
 
Net income
M $
Released
Forecast
Spread
-302
-310
2,5%
-198
-202
2,1%
-403
-385
-4,5%
-187
-238
21%
-454
-423
-7,2%
 
-684
 
EPS
$
Released
Forecast
Spread
-7,12
-7,30
2,4%
-3,97
-4,03
1,4%
-7,12
-6,84
-4,0%
-3,07
-3,88
21%
-6,70
-6,20
-8,1%
 
-9,76
 
Announcement Date02/20/201802/19/201902/13/202002/11/202102/10/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
81,6
81,5
0,13%
83,4
83,7
-0,34%
79,9
84,2
-5,1%
89,3
87,3
2,3%
90,7
95,7
-5,2%
 
105
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-86,6
-58,7
-47%
-99,0

 


 
-137
-114
-20%
-220
-106
-108%
 
-135
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-89,8
-92,4
2,7%
-103
-95,0
-8,0%
-137
-116
-17%
-142
-117
-21%
-225
-155
-45%
 
-145
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-72,8
-99,5
27%
-122
-95,9
-28%
-152
-116
-30%
-158
-116
-36%
-239
-164
-45%
 
-159
 
Net income
M $
Released
Forecast
Spread
-73,0
-97,8
25%
-122
-93,1
-32%
-152
-120
-27%
-158
-121
-31%
-245
-163
-50%
 
-154
 
EPS
$
Released
Forecast
Spread
-1,08
-1,42
24%
-1,79
-1,35
-33%
-2,19
-1,78
-23%
-2,26
-1,77
-28%
-3,50
-1,84
-90%
 
-2,02
 
Announcement Date11/02/202102/10/202205/05/202207/28/202211/02/2022-
Previous year Next Year
Upcoming sector events for ULTRAGENYX PHARMACEUTICAL INC.
More events
Past sector events for ULTRAGENYX PHARMACEUTICAL INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise